Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Comment by StevenBirchon Apr 02, 2022 11:24am
227 Views
Post# 34569979

RE:RE:RE:Who is the suitor in a buyout

RE:RE:RE:Who is the suitor in a buyout I think a JV is more likely in the short term and I wouldn't be surprised if preliminary talks have already taken place, maybe a deal in place pending BTD.

I can't believe that they are waiting for more data just for us and if nothing's cooking then why not just give us the usual update, it can't be that onerous of a task for them. So by waiting a little bit here are they trying to impress the FDA and/or any possible partners?

I think success with NMIBC is being used to finance their future plans and then it will be clearer just what this great little company is worth and the bidding war can begin. I think I've already spent $12 worth in my head but these buyouts are also reported in US$ so that shouldn't be a problem. 

I akso don't think we see a buyout until Roger is back in charge and that would be fitting in my opinion.
<< Previous
Bullboard Posts
Next >>